Kinoxis Therapeutics
PrivateLast Round
Grant
Dec 23, 2024
Total Funding Raised
$22.37M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Kinoxis Therapeutics is a biotechnology company developing novel small-molecule therapies for the treatment of neuropsychiatric disorders, including substance use disorders, agitation, and aggression.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Mental Health
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kinoxis Therapeutics Comparables
Compare Kinoxis Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Astraea Therapeutics | 80% | |
| Occentis | 80% | |
| Proniras Corporation | 76% | |
Kinoxis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 23, 2024 | ||||
| Series B | Aug 12, 2024 | ||||
| Grant | Jun 8, 2023 | ||||
| VC Round | Dec 22, 2020 | ||||
| Grant | Sep 29, 2019 | ||||
Series A | Feb 15, 2018 |
Key People
Founding team and executive leadership
Kinoxis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Drug Abuse | Grant |
| CUREator | Grant |
| NIH RADx | Grant |
| UniSuper Management | Series B |
| Avicella Capital | Series B |
| National Institutes of Health (NIH) | Grant |
| Uniseed | VC Round, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 58% MoM.
- May 16, 2026
Monthly visitors grew 107% MoM, reaching 505.
Kinoxis Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kinoxis Therapeutics's valuation, stock price, and market status.